Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin Alfa in CHF and Anemia
NCT00086086Phase 2Completed
- Sponsor
- Amgen
- Start
- Aug 2003
- Modality
- Erythropoietins, Colony Stimulating Factors
01
Overview
A Phase 2 trial of darbepoetin alfa in anemia, sponsored by Amgen. Started Aug 2003; status: completed.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00086086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00086086.